AC Immune SA reported earnings results for the third quarter and nine months ended September 30, 2023. For the third quarter, the company reported net loss was CHF 15.14 million compared to CHF 13.52 million a year ago. Basic loss per share from continuing operations was CHF 0.18 compared to CHF 0.16 a year ago.
For the nine months, net loss was CHF 49.49 million compared to CHF 52 million a year ago. Basic loss per share from continuing operations was CHF 0.59 compared to CHF 0.62 a year ago.